Barro, Alixa E.

HRN: 29-17-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/18/2026
06/25/2026
IV
900 Mg
Q8
Abortion
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: